Welcome to My Blog
Here is a masonry blog layout with no sidebarCountries facing pressure to loosen virus restrictions
Some European nations have started tentative moves to ease their shutdowns. Hard-hit Spain, which on Sunday reported its lowest daily growth in infections in three weeks, will allow workers in some nonessential industries to return to factories and construction sites Monday.
South Korea’s caseload has slowed from early March, when it was reporting around 500 new cases a day, but officials have warned of a broader quiet spread, pointing to transmissions at locations such as bars that may indicate eased attitudes toward social distancing.
Covid-19: Domestic passenger vehicle sales plunge 51% in March: SIAM
Caronavirus Pandemic: Can beer help with coronavirus?:Serious to foolish queries flood helplines
Vishal Sehgal, medical director at Bangalore-based Portea Medical, said their WhatsApp chatbot service, launched in the third week of March, has received over 15 lakh queries from over 16 countries. Besides, they get over 100 COVID-19 related calls on their helpline everyday.
“There is a lot of anxiety and doubts among people about COVID-19. They are mostly about what this virus is, how it works and what safety measures need to be taken. There are also a lot of queries on what one can do if they develop the symptoms.
ADB triples financial aid for members to $20 billion to fight virus
French insurers in talks to jointly invest 1 bln euros to help small businesses during coronavirus
Markel International appoints Bo Yu as claims lead for Asia
In this role, Bo will be the first point of contact for all claims arising through Markel’s offices in Singapore, Hong Kong, India and Labuan. He will work closely with the extensive claims team across the Markel group, ensuring the best expertise is always provided to clients throughout the claims process. Bo will also help Markel better engage with its partners across the region by offering specific claims training as and when required.
Covid-19 Crisis:IRDAI asks insurers to be cautious on dividend payments,rationalise expenses and ensure solvency margin
Emphasising on prudent management of financial resources by the domestic insurers in the days of Covid-19 pandemic and ongoing lockdown in the country, the board of insurers are advised to devise strategies to ensure that they have adequate capital and resources available with them, said Pravin Kutumbe, member(Finance & Investment),IRDAI in a circular to the insurers on Monday.
WHO says Covid-19 is 10 times more deadly than swine flu
Tedros lamented Monday that some countries are seeing a doubling of cases every three to four days, but stressed that if countries were committed to “early case-finding, testing, isolating (and) caring for every case and tracing every contact” they could rein in the virus.
More than half of the planet’s population is currently staying home as part of efforts to stem the spread of the virus, but Tedros warned that “our global connectedness means the risk of re-introduction and resurgence of the disease will continue”.
Only Ayushman Yojana beneficiaries can be tested for free in pvt labs: SC
“We make it clear that the benefit of free testing by a person can be availed only when he or she is covered under any scheme like Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana.We are also of the view that looking to the plight of persons belonging to economically weaker sections of the society, the Government may consider as to whether any other categories of persons belonging to economically weaker sections of the society can be extended benefit of free testing of Covid-19,” it said.
25 districts in 15 states have not reported new Covid-19 cases: Govt
Agarwal also said that the Core Strategy Group on Covid-19 was working on rapid and economical diagnostics as well as new drugs.
“The group has been formed, based on a detailed review of Covid-19 research, undertaken by Union Health Minister Harshvardhan along with CSIR and its 38 labs. The group is working on digital and molecular surveillance, rapid and economical diagnostics, new drugs, repurposing of drugs and associated production “ he said.
Nationwide lockdown extended till May 3:PM Modi
Apple, Google bring Covid-19 contact-tracing to 3 billion people
WHO is investigating reports of recovered COVID patients testing positive again
Cyber Security&Covid-19
If you have effective cyber incident response, crisis management and/or business recovery plans in place, it is important to review them in light of your new operating environment. Can you access all the equipment you will need to test or reset? Is your data still being backed up to a secure site? Can your users still effectively report phishing or other indicators of cyber incidents? How are you going to maintain communication between the key crisis managers if all your laptops and mobiles get encrypted with ransomware? If your plan isn’t tested yet, now may be the wrong time to start – but at a minimum do all the relevant staff at least have a clear understanding of the plan, and how your current situation has altered it?
Two thirds of COVID-19 patients improve after Gilead drug – NEJM
The paper’s author called the findings “hopeful,” but cautioned that it is difficult to interpret the results since they do not include comparison to a control group, as would be the case in a randomized clinical trial. In addition, the patient numbers were small, the details being disclosed are limited, and the follow-up time was relatively short.
There are currently no approved treatments or preventive vaccines for COVID-19, the respiratory illness caused by the novel coronavirus that has killed more than 100,000 people worldwide.
World Bank forecasts worst economic slump in South Asia in 40 years
Other than India, the World Bank forecast that Sri Lanka, Nepal, Bhutan and Bangladesh will also see sharp falls in economic growth.
Three other countries – Pakistan, Afghanistan and the Maldives – are expected to fall into recession, the World Bank said in the report, which was based on country-level data available as of April 7.